PT Itama Ranoraya Tbk (ISX:IRRA) EBIT : Rp2,041 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is PT Itama Ranoraya Tbk EBIT?

PT Itama Ranoraya Tbk's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was Rp8,614 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was Rp2,041 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. PT Itama Ranoraya Tbk's annualized ROC % for the quarter that ended in Mar. 2024 was 3.89%. PT Itama Ranoraya Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.97%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. PT Itama Ranoraya Tbk's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 0.22%.

PT Itama Ranoraya Tbk EBIT Historical Data

The historical data trend for PT Itama Ranoraya Tbk's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Itama Ranoraya Tbk EBIT Chart

PT Itama Ranoraya Tbk Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

44,642.80

78,916.47

149,865.41

71,365.76

22,531.61

PT Itama Ranoraya Tbk Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															12,583.40	10,456.96	-	-6,573.69	8,614.48

Competitive Comparison of PT Itama Ranoraya Tbk's EBIT

For the Medical Distribution subindustry, PT Itama Ranoraya Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Itama Ranoraya Tbk's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Itama Ranoraya Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT Itama Ranoraya Tbk's EV-to-EBIT falls into.

PT Itama Ranoraya Tbk EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp2,041 Mil.

PT Itama Ranoraya Tbk (ISX:IRRA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

PT Itama Ranoraya Tbk's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	33836.576 * ( 1 - 27.07% )	/	( (610122.033	+	660193.446)	/ 2 )
=	24677.0148768	/	635157.7395
=	3.89 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1058886.244	-	356734.455	-	( 92029.756	-	max(0, 597877.582	-	796273.546	+	92029.756	))
=	610122.033

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1071781.104	-	400999.282	-	( 10588.376	-	max(0, 606891.797	-	810965.326	+	10588.376	))
=	660193.446

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

PT Itama Ranoraya Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	34457.92	/	( ( (61112.816 + max(345821.741, 0))	+	(59789.948 + max(398483.647, 0)) )	/	2 )
=	34457.92	/	( ( 406934.557	+	458273.595 )	/	2 )
=	34457.92	/	432604.076
=	7.97 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(524574.581	+	132985.715	+	45780.465)	-	(356734.455	+	0	+	784.56500000006)
=	345821.741

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(608247.289	+	135138.904	+	56232.736)	-	(400999.282	+	0	+	136)
=	398483.647

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

PT Itama Ranoraya Tbk's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	2040.793	/	918920.491
	=	0.22 %

PT Itama Ranoraya Tbk EBIT Related Terms

Thank you for viewing the detailed overview of PT Itama Ranoraya Tbk's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Itama Ranoraya Tbk (ISX:IRRA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Itama Ranoraya Tbk (ISX:IRRA) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

MT. Haryono Square Lantai 1 Unit 101, Jl. Otto Iskandardinata Raya No. 390, No. 390 Jakarta Timur, Jakarta, IDN, 13330

Website

https://www.itama.co.id

PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. The key revenue generating segments of the company are Sterile Non-Electromedical Medical Equipment and In Vitro Diagnostic product.

PT Itama Ranoraya Tbk (ISX:IRRA) Headlines

No Headlines